News on Mesothelioma | Surviving Mesothelioma

High Dose Radiotherapy Improves Mesothelioma Survival in New Study

Treating malignant pleural mesothelioma patients with high doses of targeted radiotherapy after surgery or biopsy may significantly extend their lives. That’s the message from a multi-center mesothelioma study conducted in Italy and recently published in a French medical journal. Mesothelioma Treatment with Radiotherapy Scientists analyzed the cases of 36 malignant pleural mesothelioma patients diagnosed between 2009 and 2012. Nineteen of the patients were treated with … Continue reading High Dose Radiotherapy Improves Mesothelioma Survival in New Study »

Blocking This Cellular Process Could Help Mesothelioma Chemotherapy Work Better

Researchers in California and Boston say blocking a process by which cells break down and recycle their components into new cells could make mesothelioma tumors more susceptible to chemotherapy. Although the process, known as autophagy, is a natural part of the lives of cells, it can also be induced by certain drugs. Emerging research suggests that the multi-stage process is not only more complex than … Continue reading Blocking This Cellular Process Could Help Mesothelioma Chemotherapy Work Better »

PD-L1 Linked to Shorter Mesothelioma Survival

Mesothelioma consultation regarding treatment

Mesothelioma patients who express too much of the protein PD-L1 are less likely to survive the asbestos cancer than those whose cells express less. That is the message from a new Australian study on mesothelioma prognosis, which backs up the findings from a number of previous PD-L1 studies. In a report published in the Asia-Pacific Journal of Clinical Oncology, oncologist Bella Hai Nguyen and colleagues … Continue reading PD-L1 Linked to Shorter Mesothelioma Survival »

Better Nutrition Could Mean Longer Survival for Elderly Mesothelioma Patients

Could eating better improve elderly patient’s chances of surviving malignant pleural mesothelioma? Another new study suggests that it may. An article in the journal Surgical Oncology found that lung cancer patients who score low on a nutritional status assessment tool called the Geriatric Nutritional Risk Index (GNRI) have worse outcomes after surgery. The GNRI is a simple tool based on weight and levels of the … Continue reading Better Nutrition Could Mean Longer Survival for Elderly Mesothelioma Patients »

Immunotherapy for Mesothelioma: Who Are the Best Candidates?

Immunotherapy is emerging as one of the most promising new treatment approaches for a wide range of cancers, including malignant pleural mesothelioma, the treatment-resistant lung-related cancer caused by asbestos exposure. Every year, more than 2,500 Americans are diagnosed with pleural mesothelioma. Most will die of the illness within 18 months, even with the most advanced chemotherapeutic, radiotherapeutic, and surgical treatments. But immunotherapy, which recruits the … Continue reading Immunotherapy for Mesothelioma: Who Are the Best Candidates? »

Three-Drug Combo is New Standard of Care for Pleural Mesothelioma in France

France has a new standard of care for people with unresectable malignant pleural mesothelioma. Along with the chemotherapy drugs cisplatin and pemetrexed (Alimta), French doctors are now regularly also using bevacizumab (Avastin) to boost the effectiveness of mesothelioma chemotherapy. The addition of Avastin to standard mesothelioma care came after the 2016 French-led mesothelioma avastin cisplatin pemetrexed study (MAPS) showed that the VEGF inhibitor improved mesothelioma … Continue reading Three-Drug Combo is New Standard of Care for Pleural Mesothelioma in France »

FGFR Inhibitors May Offer New Way to Treat Malignant Pleural Mesothelioma

Drugs that inhibit a particular cell signaling pathway might offer a new way to help treat the intractable asbestos cancer, malignant mesothelioma. Fibroblast growth factor receptor (FGFR) is a tyrosine kinase signaling pathway that plays a fundamental role in the development of embryos, tissue regeneration, and the growth of new blood vessels (angiogenesis). Recent evidence suggests that it may also impact the development of cancers … Continue reading FGFR Inhibitors May Offer New Way to Treat Malignant Pleural Mesothelioma »

More Evidence that Red Wine Compound Could Fight Mesothelioma

There is more evidence that a compound derived from the resveratrol in red wine could have a role to play in the prevention and treatment of malignant pleural mesothelioma. The chemical, called pterostilbene, is a natural analog of resveratrol, a powerful polyphenol found in red wine and the skin of red grapes. Resveratrol has been studied extensively for its potential to combat treatment-resistant cancers such … Continue reading More Evidence that Red Wine Compound Could Fight Mesothelioma »

BAP1 Test Offers More Accurate Mesothelioma Diagnosis

asian doctor

A Chinese research study finds that adding a test for expression of the BAP1 tumor-suppressor protein to standard biomarker testing increases the diagnostic accuracy for malignant pleural mesothelioma to 93 percent. Pleural mesothelioma is especially challenging to diagnose and to distinguish from lung cancer. The distinction is important, however, because the two cancers respond differently to different types of drugs. In addition, the earlier malignant … Continue reading BAP1 Test Offers More Accurate Mesothelioma Diagnosis »

Age May Have Little Impact on Mesothelioma Surgery Outcomes

Being older does not necessarily reduce a patient’s odds of benefiting from mesothelioma surgery. That is the good news from a study conducted by mesothelioma experts at Glenfield Hospital in Leicester, England. The bad news is that too many elderly mesothelioma patients are not being referred for adjuvant treatments that could improve their surgical outcomes. Adjuvant Therapy and Mesothelioma Survival Adjuvant therapy is a treatment … Continue reading Age May Have Little Impact on Mesothelioma Surgery Outcomes »

Get your free copy of
“Surviving Mesothelioma” Today!